Increasing transparency and accountability in national pharmaceutical systems-Reference-Cited by-同舟云学术

Increasing transparency and accountability in national pharmaceutical systems

Published:2018-08-30 Issue:11 Volume:96 Page:782-791
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Paschke Anne¹,Dimancesco Deirdre²,Vian Taryn³,Kohler Jillian C⁴,Forte Gilles²

Affiliation:

1. Department of Political Sciences, University of Hamburg, Max-Brauer-Allee 60, 22767 Hamburg, Germany.

2. WHO Essential Medicines and Health Products Department, World Health Organization, Geneva, Switzerland.

3. School of Public Health, Boston University, Boston, United States of America.

4. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference46 articles.

1. Resolution A/RES/70/1. Transforming our world: the 2030 agenda for sustainable development. In: Seventieth United Nations General Assembly, New York, 25 September 2015. New York: United Nations; 2015. Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E [cited 2018 Aug 27].

2. Sustainable Development Goal 3: ensure healthy lives and promote well-being for all at all ages. New York: United Nations; 2018. Available from: http://www.un.org/sustainabledevelopment/health/ [cited 2017 Aug 19].

3. Making fair choices on the path to universal health coverage. Final report of the WHO Consultative Group on Equity and Universal Health Coverage. Geneva: World Health Organization; 2014. Available from: http://www.who.int/choice/documents/making_fair_choices/en/ [cited 2017 Dec 10].

4. Tracking universal health coverage: 2017 Global Monitoring Report. Geneva and Washington, DC: World Health Organization and The World Bank; 2017. Available from: http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/ [cited 2017 Dec 10].

5. Coping with out-of-pocket health payments: empirical evidence from 15 African countries.;Leive;Bull World Health Organ,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China;Frontiers in Pharmacology;2024-08-20

2. Transparency interventions to improve health system outcomes in low and middle-income countries: a narrative systematic review;BMJ Open;2024-06

3. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance;Global Public Health;2024-05-16

4. Drug pricing and transparency in Europe and the United States: what is it and how does it work?;Expert Review of Pharmacoeconomics & Outcomes Research;2024-02

5. Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role?;Management Matters;2024-01-03